Advertisement

Topics

High level of heart disease pipeline innovation could bridge unmet need in treating CVD

04:21 EDT 24 Aug 2017 | Topix

With over 1,400 products in active development, the innovation pipeline for cardiovascular disease is extensive, with four key CVD indications hypertension, heart failure, dyslipidemia and thrombosis now accounting for around half of all pipeline innovation, according to GBI Research, a recognized leader in providing business information and analytics. The company's latest report on cardiovascular disease looks at the current clinical and commercial landscape and highlights the particularly high level of heart failure pipeline innovation.

Original Article: High level of heart disease pipeline innovation could bridge unmet need in treating CVD

NEXT ARTICLE

More From BioPortfolio on "High level of heart disease pipeline innovation could bridge unmet need in treating CVD"

Advertisement
Quick Search
Advertisement
Advertisement